532 reports of this reaction
2.1% of all DIROXIMEL FUMARATE reports
#10 most reported adverse reaction
MEMORY IMPAIRMENT is the #10 most commonly reported adverse reaction for DIROXIMEL FUMARATE, manufactured by Biogen Inc.. There are 532 FDA adverse event reports linking DIROXIMEL FUMARATE to MEMORY IMPAIRMENT. This represents approximately 2.1% of all 25,327 adverse event reports for this drug.
Patients taking DIROXIMEL FUMARATE who experience memory impairment should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MEMORY IMPAIRMENT is a less commonly reported adverse event for DIROXIMEL FUMARATE, but still significant enough to appear in the safety profile.
In addition to memory impairment, the following adverse reactions have been reported for DIROXIMEL FUMARATE:
The following drugs have also been linked to memory impairment in FDA adverse event reports:
MEMORY IMPAIRMENT has been reported as an adverse event in 532 FDA reports for DIROXIMEL FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MEMORY IMPAIRMENT accounts for approximately 2.1% of all adverse event reports for DIROXIMEL FUMARATE, making it a notable side effect.
If you experience memory impairment while taking DIROXIMEL FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.